Prelude Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,988
| Closed | -$15K | – | 1806 |
|
|
2019
Q4 | $15K | Buy |
2,988
+2,448
| +453% | +$12.3K | ﹤0.01% | 1201 |
|
|
2019
Q3 | $3K | Sell |
540
-60
| -10% | -$333 | ﹤0.01% | 1108 |
|
|
2019
Q2 | $4K | Buy |
600
+96
| +19% | +$640 | ﹤0.01% | 1147 |
|
|
2019
Q1 | $2K | Buy |
+504
| New | +$2K | ﹤0.01% | 1295 |
|
|
2018
Q3 | – | Sell |
-9,656
| Closed | -$78K | – | 1816 |
|
|
2018
Q2 | $78K | Buy |
+9,656
| New | +$78K | ﹤0.01% | 786 |
|
|
2017
Q2 | – | Sell |
-4,023
| Closed | -$38K | – | 1878 |
|
|
2017
Q1 | $38K | Sell |
4,023
-1,077
| -21% | -$10.2K | ﹤0.01% | 1063 |
|
|
2016
Q4 | $44K | Buy |
+5,100
| New | +$44K | 0.01% | 1038 |
|
|
2015
Q4 | – | Sell |
-9,239
| Closed | -$53K | – | 1705 |
|
|
2015
Q3 | $53K | Sell |
9,239
-461
| -5% | -$2.65K | 0.01% | 970 |
|
|
2015
Q2 | $72K | Sell |
9,700
-4,300
| -31% | -$31.9K | 0.01% | 948 |
|
|
2015
Q1 | $84K | Sell |
14,000
-6,800
| -33% | -$40.8K | 0.01% | 1039 |
|
|
2014
Q4 | $157K | Buy |
+20,800
| New | +$157K | 0.02% | 739 |
|
|
2014
Q2 | – | Sell |
-3,500
| Closed | -$14K | – | 2058 |
|
|
2014
Q1 | $14K | Buy |
+3,500
| New | +$14K | ﹤0.01% | 1553 |
|